Bb5a31f81ClaimDuring Project BioShield testing, Agarikon (Laricifomes officinalis) mycelial extracts demonstrated antiviral activity against orthopoxviruses and influenza virusesAgreeDisagree
Bb5a31f81ClaimIn a clinical trial conducted through UC San Diego and UCLA, co-administration of Agarikon and Turkey Tail mycelium with COVID-19 mRNA vaccines statistically significantly reduced adverse reactionsAgreeDisagree
Bb5a31f81ClaimThe highly pathogenic avian influenza H5N1 has documented cross-species transmission to at least 90 mammal speciesAgreeDisagree
Bb5a31f81ClaimThe estimated human fatality rate for H5N1 avian influenza infection ranges between 40 and 50 percentAgreeDisagree
Bb5a31f81ClaimVaccinated individuals receiving Agarikon and Turkey Tail mycelium maintained triple the antibody titer reservoirs against COVID-19 six months post-vaccination compared to vaccination aloneAgreeDisagree
Bb5a31f81ClaimPhysician Edward Jenner developed the first smallpox vaccine in the eighteenth century using the cowpox virusAgreeDisagree
Bb5a31f81ClaimManaging human immunodeficiency virus infection requires multidrug cocktail regimens to prevent the emergence of drug-resistant viral mutationsAgreeDisagree
Bb5a31f81ClaimFecal microbiota transplantation is commonly used in medical settings to treat recurrent Clostridioides difficile infectionsAgreeDisagree
Bb5a31f81ClaimModerna developed an mRNA-based influenza vaccine candidate in a joint investment venture with BlackstoneAgreeDisagree
Bb5a31f81ClaimThe Food and Drug Administration Center for Biologics Evaluation and Research vaccine division was led by a former head of vaccine development at MerckAgreeDisagree
Bb5a31f81ClaimClinical trials for Moderna's mRNA influenza vaccine demonstrated an absolute risk reduction rate of 0.8 percentAgreeDisagree
Bb5a31f81ClaimRestricting sleep to four hours per night significantly reduces human antibody production in response to vaccinesAgreeDisagree
Bb5a31f81ClaimImmune cells coordinate their activities and pathogen responses by transmitting signaling proteins called cytokinesAgreeDisagree
Bb5a31f81ClaimMost pathogenic viruses multiply less effectively at higher human body temperaturesAgreeDisagree
Bb5a31f81ClaimExposure to cold weather or having wet hair does not lower core body temperature enough to induce a viral coldAgreeDisagree
Bb5a31f81ClaimFever occurs when immune cells detect an infection and release molecules that signal the brain to raise body temperatureAgreeDisagree
Bb5a31f81ClaimViruses causing common colds survive longer outside the body and in respiratory droplets under cold temperaturesAgreeDisagree
Bb5a31f81ClaimHuman respiratory mucus contains specialized molecules that directly neutralize virusesAgreeDisagree
Bb5a31f81ClaimMany human immune cells operate more effectively at a slightly elevated body temperatureAgreeDisagree
Bb5a31f81ClaimJoshua Monrad categorizes biological risks into four phases: human-created bioweapons, AI-enabled human uplift, AI agents socially engineering humans, and end-to-end autonomous AI bioweapon executionAgreeDisagree